Corvus PharmaceuticalsCRVS
那斯達克 · USD
10.56
-0.18
(-1.68%)
收盤 10/07 03:59 (UTC+8)
10/07 03:59 (UTC+8)
Corvus PharmaceuticalsCRVS
10.56
-0.18
(-1.68%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 19,297 | 14,877 | 12,217 | 10,572 | 10,260 | - | - | - | - | - |
研發費用 | 15,964 | 11,175 | 9,939 | 8,454 | 7,873 | 7,453 | 5,974 | 5,222 | 4,114 | 4,075 |
推銷及管理費用 | 3,333 | 3,702 | 2,278 | 2,118 | 2,387 | 2,469 | 2,131 | 2,033 | 1,821 | 2,178 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -19,297 | -14,877 | -12,217 | -10,572 | -10,260 | -9,922 | -8,105 | -7,255 | -5,935 | -6,253 |
其他收入及費用 | 2,047 | 1,784 | 603 | 738 | 2,651 | 25,654 | -1,834 | -32,280 | 2,250 | 316 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -17,250 | -13,093 | -11,614 | -9,834 | -7,609 | 15,732 | -9,939 | -39,535 | -3,685 | -5,937 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -17,959 | -13,692 | -12,321 | -10,157 | -7,998 | 15,193 | -12,113 | -40,217 | -4,262 | -5,701 |
基本每股稅後盈餘(元) | -0.19 | -0.15 | -0.15 | -0.12 | -0.10 | 0.21 | -0.18 | -0.60 | -0.07 | -0.12 |
稀釋每股稅後盈餘(元) | -0.20 | -0.15 | -0.15 | -0.12 | -0.13 | -0.13 | -0.16 | -0.68 | -0.06 | -0.12 |
基本平均股數(千股) | 92368.00 | 89996.00 | 82960.00 | 82836.00 | 77774.00 | 72126.00 | 68347.00 | 66701.00 | 59710.00 | 49038.00 |
稀釋平均股數(千股) | 92368.00 | 89996.00 | 82960.00 | 82836.00 | 77774.00 | 75152.00 | 68347.00 | 66701.00 | 59710.00 | 49038.00 |
還原基本每股稅後盈餘(元) | -0.19 | -0.15 | -0.15 | -0.12 | -0.10 | 0.21 | -0.18 | -0.60 | -0.07 | -0.12 |
還原稀釋每股稅後盈餘(元) | -0.20 | -0.15 | -0.15 | -0.12 | -0.13 | -0.13 | -0.16 | -0.68 | -0.06 | -0.12 |
還原基本平均股數(千股) | 92,368 | 89,996 | 82,960 | 82,836 | 77,774 | 72,126 | 68,347 | 66,701 | 59,710 | 49,038 |
還原稀釋平均股數(千股) | 92,368 | 89,996 | 82,960 | 82,836 | 77,774 | 75,152 | 68,347 | 66,701 | 59,710 | 49,038 |
EBITDA(千元) | -17,740 | -13,680 | -12,556 | -10,588 | -8,303 | 14,924 | -12,335 | -40,720 | -4,465 | -5,829 |